Clinical trial
The Effect of Hybrid Closed-loop Systems on Markers of Endothelial, Myocardial and Vascular Function in Patients With Type 1 Diabetes.
NCT07241702 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Hybrid Closed-loop Systems on Markers of Endothelial, Myocardial and Vascular Function in Patients With Type 1 Diabetes.
- Lead sponsor
- Attikon Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 1, 2019
- Completion date
- December 1, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes